Form 8-K - Current report:
SEC Accession No. 0000950170-25-102353
Filing Date
2025-08-05
Accepted
2025-08-05 06:04:10
Documents
11
Period of Report
2025-08-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K idya-20250805.htm   iXBRL 8-K 51683
2 EX-99.1 idya-ex99_1.htm EX-99.1 161741
  Complete submission text file 0000950170-25-102353.txt   338081

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT idya-20250805.xsd EX-101.SCH 28735
13 EXTRACTED XBRL INSTANCE DOCUMENT idya-20250805_htm.xml XML 4724
Mailing Address 5000 SHORELINE CT, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 5000 SHORELINE CT, SUITE 300 SOUTH SAN FRANCISCO CA 94080 650-443-6209
IDEAYA Biosciences, Inc. (Filer) CIK: 0001676725 (see all company filings)

EIN.: 474268251 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)